Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_assertion description "[The gain-of-function produced by the Gly-9 variant may explain why drugs active against tremor in Parkinson's disease (PD) are usually not effective in the treatment of ET and suggests that DRD3 partial agonists or antagonists should be considered as novel therapeutic options for patients with ET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_assertion evidence source_evidence_literature NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_assertion SIO_000772 16809426 NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_assertion wasDerivedFrom befree-20140225 NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_assertion wasGeneratedBy ECO_0000203 NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP529514.RAR511BH2099H06Vx0KP0RhokgBqzu6FF0ozMfQJBFpCU130_provenance.